Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHANGHAI STOCK EXCHANGE  >  Jiangsu Hengrui Medicine Co., Ltd.    600276   CNE0000014W7

JIANGSU HENGRUI MEDICINE CO., LTD.

(600276)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
02/21/2020 02/24/2020 02/25/2020 02/26/2020 02/27/2020 Date
90.2(c) 88.38(c) 88.31(c) 86.68(c) 87.21 Last
19 334 718 27 950 756 23 184 351 22 998 536 19 002 179 Volume
-0.66% -2.02% -0.08% -1.85% +0.61% Change
More quotes
Financials (CNY)
Sales 2019 23 352 M
EBIT 2019 5 796 M
Net income 2019 5 214 M
Finance 2019 8 844 M
Yield 2019 0,21%
Sales 2020 29 432 M
EBIT 2020 7 532 M
Net income 2020 6 742 M
Finance 2020 13 103 M
Yield 2020 0,27%
P/E ratio 2019 73,4x
P/E ratio 2020 56,9x
EV / Sales2019 16,0x
EV / Sales2020 12,5x
Capitalization 382 B
More Financials
Company
Jiangsu Hengrui Medicine Co., Ltd. specializes in the research, development, manufacture and marketing of pharmaceutical products. The activity is organized primarily around 5 families of products: - anti-tumor drugs (No. 1 Chinese); - Anesthetic drugs; - contrast agents: used in medical... 
Sector
Pharmaceuticals
Calendar
03/03Earnings Release
More about the company
Surperformance© ratings of Jiangsu Hengrui Medicine C
Trading Rating : Investor Rating :
More Ratings
Latest news on JIANGSU HENGRUI MEDICINE C
01/21How a virus impacts the economy and markets
RE
2019JIANGSU HENGRUI MEDICINE : Mycovia Pharmaceuticals and Jiangsu Hengrui Medicine ..
AQ
2019JIANGSU HENGRUI MEDICINE : Mycovia Pharmaceuticals and Jiangsu Hengrui Medicine ..
AQ
2019JIANGSU HENGRUI MEDICINE : Mycovia Pharmaceuticals and Jiangsu Hengrui Medicine ..
BU
2019JIANGSU HENGRUI MEDICINE : LSK BioPharma and Jiangsu Hengrui Medicine Announce F..
AQ
2019JIANGSU HENGRUI MEDICINE CO. : Ex-dividend day for final dividend
FA
2019JIANGSU HENGRUI MEDICINE CO. : 20% Stock Dividend
FA
2018JIANGSU HENGRUI MEDICINE CO LTD : Ex-dividend day for final dividend
FA
2018JIANGSU HENGRUI MEDICINE CO LTD : BONUS ISSUE: 3 new shares for 10 existing shar..
FA
2018JIANGSU HENGRUI MEDICINE CO LTD : annual earnings release
2018JIANGSU HENGRUI MEDICINE : and Arcutis Announce a Development and Commercializat..
BU
2017JIANGSU HENGRUI MEDICINE CO., LTD : 20% Stock Dividend
FA
2017JIANGSU HENGRUI MEDICINE CO., LTD : Ex-dividend day for final dividend
FA
2016JIANGSU HENGRUI MEDICINE CO., LTD : 20% Stock Dividend
FA
2016JIANGSU HENGRUI MEDICINE CO., LTD : Ex-dividend day for final dividend
FA
More news
News in other languages on JIANGSU HENGRUI MEDICINE C
02:45aJIANGSU HENGRUI MEDICINE CO., LTD. : Veröffentlichung des Jahresergebnisses
02:45aJIANGSU HENGRUI MEDICINE CO., LTD. : publication des résultats annuels
2019JIANGSU HENGRUI MEDICINE CO. : 20% Stock Dividend
2019JIANGSU HENGRUI MEDICINE CO. : Ex-dividend day for final dividend
2018JIANGSU HENGRUI MEDICINE CO LTD : BONUS ISSUE: 3 new shares for 10 existing shar..
More news
Analyst Recommendations on JIANGSU HENGRUI MEDICINE C
More recommendations
Sector news : Pharmaceuticals - NEC
02:52aHIKMA PHARMACEUTICALS : forecasts 2020 growth after its profit tops as treatment..
RE
02:51aBayer Head Quits Amid Roundup Woe -- WSJ
DJ
02:22aBAYER : Increases 4Q Earnings, Sales Amid Rising Number Of Glyphosate Plaintiffs
DJ
01:58aBAYER : targets 9.6% gain in 2020 adjusted EBITDA
RE
02/26India Tribunal Approves Merger Of Unilever, GlaxoSmithKline Units
DJ
More sector news : Pharmaceuticals - NEC
Chart JIANGSU HENGRUI MEDICINE CO., LTD.
Duration : Period :
Jiangsu Hengrui Medicine Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JIANGSU HENGRUI MEDICINE C
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 23
Average target price 99,17  CNY
Last Close Price 86,68  CNY
Spread / Highest target 26,9%
Spread / Average Target 14,4%
Spread / Lowest Target -10,8%
EPS Revisions
Managers
NameTitle
Yun Shu Zhou General Manager & Director
Wei Dong Chairman-Supervisory Board
Piao Yang Sun Chairman
Song Zhou Chief Financial Officer
Xin Hua Jiang Vice Chairman
Sector and Competitors
1st jan.Capitalization (M$)
JIANGSU HENGRUI MEDICINE CO., LTD.-0.96%54 364
JOHNSON & JOHNSON-0.84%378 557
ROCHE HOLDING AG5.13%287 870
MERCK AND COMPANY-12.11%203 526
NOVARTIS-5.57%200 481
PFIZER, INC.-13.40%192 145